| Original language | English |
|---|---|
| Pages (from-to) | 102-105 |
| Number of pages | 4 |
| Journal | Oncologist |
| Volume | 29 |
| Issue number | 2 |
| DOIs |
|
| Publication status | Published - Feb 2024 |
Funding
Alfred I. Neugut reported consulting for Otsuka, GlaxoSmithKline, Value Analytics, United Biosource Corporation, and Eisai, grant support from Otsuka, medical advisory board for EHE International, and scientific advisory board for Organon. Antonio Tito Fojo indicated no financial relationships.
| Funders | Funder number |
|---|---|
| Otsuka America | |
| Eisai |
ASJC Scopus Subject Areas
- General Medicine
